Drug Database
R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
Approved by UK Medicines & Healthcare Products Regulatory Agency & the European Medicines Agency.
- R03AC02 salbutamol
- R03AC03 terbutaline
- R03AC12 salmeterol
- R03AC13 formoterol
- R03AC18 indacaterol
- R03AC19 olodaterol
- R03AK04 salbutamol and sodium cromoglicate
- R03AK06 salmeterol and fluticasone
- R03AK07 formoterol and budesonide
- R03AK08 formoterol and beclometasone
- R03AK10 vilanterol and fluticasone furoate
- R03AK11 formoterol and fluticasone
- R03AK14 indacaterol and mometasone
- R03AL02 salbutamol and ipratropium bromide
- R03AL03 vilanterol and umeclidinium bromide
- R03AL04 indacaterol and glycopyrronium bromide
- R03AL05 formoterol and aclidinium bromide
- R03AL06 olodaterol and tiotropium bromide
- R03AL07 formoterol and glycopyrronium bromide
- R03AL08 vilanterol, umeclidinium bromide and fluticasone furoate
- R03AL09 formoterol, glycopyrronium bromide and beclometasone
- R03AL11 formoterol, glycopyrronium bromide and budesonide
- R03AL12 indacaterol, glycopyrronium bromide and mometasone
- R03BA01 beclometasone
- R03BA02 budesonide
- R03BA05 fluticasone
- R03BA07 mometasone
- R03BA08 ciclesonide
- R03BB01 ipratropium bromide
- R03BB04 tiotropium bromide
- R03BB05 aclidinium bromide
- R03BB06 glycopyrronium bromide
- R03BB07 umeclidinium bromide
- R03BC01 cromoglicic acid
- R03CA02 ephedrine
- R03CC02 salbutamol
- R03CC03 terbutaline
- R03CC12 bambuterol
- R03CC53 terbutaline, combinations
- R03DA04 theophylline
- R03DA05 aminophylline
- R03DC03 montelukast
- R03DX05 omalizumab
- R03DX07 roflumilast
- R03DX08 reslizumab
- R03DX09 mepolizumab
- R03DX10 benralizumab
- R03DX11 tezepelumab
Learning Zones
Disclaimer
The drug SPC information (indications, contra-indications, interactions, etc), has been developed in collaboration with eMC (www.medicines.org.uk/emc/). Medthority offers the whole library of SPC documents from eMC.
Medthority will not be held liable for explicit or implicit errors, or missing data.
Drug Licencing
Drugs appearing in this section are approved by UK Medicines & Healthcare Products Regulatory Agency (MHRA), & the European Medicines Agency (EMA).